LumiraDx Ltd competitors & alternatives

Chembio DiagnosticsMedical DiagnosticsUnited States

71% match

Medical Diagnostics

Chembio Diagnostics develops and manufactures rapid point-of-care diagnostic tests for infectious diseases, tropical fever, respiratory diseases, and veterinary health.

SeegeneBiotechnology, HealthcareSouth Korea

70% match

Biotechnology, Healthcare

Seegene provides molecular diagnostics products and technologies, including high-multiplex syndromic assays, automated instruments, and software systems. The company serves global healthcare and research partners by offering diagnostic solutions and a data platform for infectious disease detection and surveillance.

Immy Inc.Medical DiagnosticsUnited States

70% matchPrivate

Medical Diagnostics

Immy Inc. develops, manufactures, and distributes diagnostic tests, reagents, and processing systems specializing in mycology. The company serves healthcare professionals, reference laboratories, and hospital settings by providing lateral flow assays, enzyme immunoassays, and PCR tests for the detection of fungal diseases.

Biotech

Nanopath is a biotechnology and diagnostics company developing rapid molecular testing systems, with an emphasis on decentralized point-of-care testing. Its products are intended for healthcare providers and clinical laboratories, including applications in women’s health and infectious-disease diagnosis.

Similar diagnostics company

Linear Diagnostics Limited, trading as ExGen Dx, is a next-generation near-patient diagnostics company located at the BioHub Birmingham in Birmingham, United Kingdom.

Anbio BiotechnologyNNNN · BiotechFrankfurt am Main, Germany

69% matchPublic

Biotech

Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.

Biotech

INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD. is a Chinese in-vitro diagnostics company that develops and manufactures rapid immunodiagnostic and molecular diagnostic products, including infectious-disease testing kits. Its customers include clinical laboratories, hospitals, public-health organizations, and diagnostic distributors.

Biotechnology

Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The company is developing T cell-based test technologies intended to support an immunology profiling platform, with potential applications in post-acute infection syndromes, including Long COVID, and other chronic conditions linked to immune dysregulation.

Medical Diagnostics

Global BioDiagnostics Corp. (Bio-Diagnostics) researches, develops, and manufactures diagnostic products and provides laboratory testing services for dermatology, immunology, and immunohistochemistry. The company serves NHS and private clinics across the UK by supplying tools such as skin prick test accessories, patch testing ranges, autoimmune diagnostics, and rapid antibody testing solutions.

ACES Diagnostics, Inc.DiagnosticsUnited States

68% match

Similar diagnostics company

ACES Diagnostics, Inc. has developed LymeSeek, a multiplexed Luminex-based immunoassay designed to provide accurate diagnostic solutions for Lyme disease.

NOVACYT S.A. EUR1/15TH (CDI)NCYT · BiotechLe Vésinet, France

67% matchPublic

Biotech

Novacyt S.A., together with its associated entities, specializes in the research, production, contract design, and market launch of diagnostic solutions. These offerings are primarily developed for the detection of cancer and a range of infectious diseases. The company maintains an extensive international operational footprint, encompassing the United Kingdom, the broader European continent, the United States, the Asia Pacific region, the Middle East, and Africa. Its operations are segmented into three core divisions: Primer Design, Lab21 Products, and IT-IS International. The Primer Design segment is dedicated to the conceptualization, manufacturing, and commercialization of molecular real-time qPCR testing equipment and corresponding reagents, specifically for infectious disease diagnostics. The Lab21 Products division focuses on the development, production, and supply of various protein-based in-vitro diagnostic (IVD) devices that target infectious illnesses. Meanwhile, IT-IS International is responsible for engineering and fabricating PCR devices utilized within both the life sciences and food testing industries. Novacyt serves a diverse client base, including healthcare institutions and corporate organizations. The company was established in 2006 and is headquartered in Vélizy-Villacoublay, France.

Nuclein, LLCMedical DiagnosticsUnited States

67% matchPrivate

Medical Diagnostics

Nuclein, LLC develops the DASH Rapid PCR System and associated test cartridges designed to provide lab-quality diagnostic results for point-of-care settings. The system delivers multiplex PCR test results for viruses such as SARS-CoV-2 and Flu A/B within 15 minutes, serving healthcare providers in clinics and urgent care facilities.